MAPT and Alzheimer disease: Our sample, while extremely well characterized with respect to clinical, sleep and HRV features, did not have investigation for Alzheimer’s disease biomarkers, such as amyloid and/or tau positron emission tomography scanning, so we were unable to delineate the likely pathology underpinning their cognitive profile.